Related Experiment Videos
Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study.
Pediatrics
|October 1, 1985
Summary
Extracorporeal membrane oxygenation (ECMO) significantly improves survival rates in newborns with severe respiratory failure. This method allows lungs to rest, offering a better alternative to conventional ventilator therapy for high-risk infants.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
- Respiratory Physiology
Background:
- Severe respiratory failure poses a significant mortality risk in newborns.
- Conventional ventilator therapy has limitations in managing critical neonatal respiratory conditions.
Purpose of the Study:
- To evaluate the efficacy of extracorporeal membrane oxygenation (ECMO) versus conventional treatment for neonatal respiratory failure.
- To assess survival rates and complications associated with ECMO in high-risk newborns.
Main Methods:
- A prospective controlled randomized study utilizing the "randomized play-the-winner" statistical method.
- Sequential patient allocation based on treatment success to optimize resource allocation.
- Inclusion criteria: newborns with birth weight > 2 kg and objective criteria for high mortality risk.
Main Results:
- One patient received conventional treatment and died; 11 patients received ECMO and all survived.
- One case of intracerebral hemorrhage occurred among the 11 survivors treated with ECMO.
- ECMO demonstrated a marked survival advantage over conventional therapy in this cohort.
Conclusions:
- Extracorporeal membrane oxygenation is a highly effective treatment for newborns with severe respiratory failure.
- ECMO facilitates lung rest, leading to improved survival outcomes compared to conventional ventilation.
- The "play-the-winner" method efficiently allocated patients to the more successful ECMO treatment.